YOON, SEONG JUNKR,윤성준,KANG, SANG HYEONKR,강상현,JUN, SOO YOUNKR,전수연,PAIK, HYOUNG ROKKR,백형록,SON, JEE SOOKR,손지수,KIM, BYUNG KUKKR,김병국,SHIN, HEE JEONGKR,신희정
申请号：
KR1020140191676
公开号：
KR1020160080176A
申请日:
2014.12.29
申请国别(地区):
KR
年份:
2016
代理人:
摘要：
The present invention relates to Myoviridae bacteriophage Esc-CHP-1 (Accession number KCTC 12660BP) characterized in that it has a genome represented by sequence number 1 having an ability that is capable of specifically annihilating enterohemorrhagic Escherichia coli, and a method for preventing and treating the infection of enterohemorrhagic Escherichia coli using a composition comprising Myoviridae bacteriophage Esc-CHP-1 (Accession number KCTC 12660BP) as its active component. A method for preventing and treating the infection of enterohemorrhagic Escherichia coli using a composition comprising bacteriophage Esc-CHP-1 as an active component according to the present invention is capable of providing a merit of a very high peculiarity with respect to enterohemorrhagic Escherichia coli compared to a method based on chemical materials such as existing antibiotics and others. Further, the present invention is also capable of providing a merit that the present invention is very naturally friendly since the present invention uses the bacteriophage as an active component of the composition by separating bacteriophage that is already been existed in the natural world.COPYRIGHT KIPO 2016본 발명은 장출혈성 대장균을 특이적으로 사멸시킬 수 있는 능력을 갖는 서열번호 1로 표시되는 유전체를 갖는 것을 특징으로 하는 자연으로부터 분리한 미오비리대 박테리오파지 Esc-CHP-1 (수탁번호 KCTC 12660BP), 및 이를 유효성분으로 포함하는 조성물을 이용한 장출혈성 대장균의 감염을 방지 및 처치하는 방법에 관한 것이다.
